LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.82 | 17.25 | 1505 | 800 | 1.8801 | 1.2416 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.82 | 17.25 | 1 | 800 | 0.0012 | -0.4022 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 18.82 | 17.25 | 1454 | 800 | 1.8164 | 1.2277 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 972 | 1001 | 0.9704 | 0.9898 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 1314 | 1001 | 1.3118 | 1.0948 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 215 | 1001 | 0.2147 | 0.5381 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 1174 | 1001 | 1.1721 | 1.0549 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 1 | 1001 | 0.0010 | -0.3849 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 1719 | 1001 | 1.7162 | 1.1931 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 2 | 1001 | 0.0020 | -0.3077 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 20.79 | 17.25 | 1625 | 1001 | 1.6223 | 1.1722 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1251 | 1193 | 1.0481 | 1.0154 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1397 | 1193 | 1.1704 | 1.0522 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 337 | 1193 | 0.2824 | 0.6262 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1271 | 1193 | 1.0649 | 1.0207 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1790 | 1193 | 1.4997 | 1.1371 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1 | 1193 | 0.0008 | -0.3725 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 22.76 | 17.25 | 1746 | 1193 | 1.4628 | 1.1284 | MN20160310_N02 | H15 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1402 | 1290 | 1.0866 | 1.0269 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1493 | 1290 | 1.1572 | 1.0475 | MN20160310_N02 | D03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 435 | 1290 | 0.3372 | 0.6795 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1326 | 1290 | 1.0277 | 1.0088 | MN20160310_N02 | D05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1 | 1290 | 0.0008 | -0.3672 | MN20160310_N02 | G14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00021667 | 24.73 | 17.25 | 1944 | 1290 | 1.5067 | 1.1361 | MN20160310_N02 | G14 |